Want to learn more about XIAFLEX®? Request a representative, register to receive updates about XIAFLEX®, or both.
Important Safety Information for XIAFLEX®
XIAFLEX® is indicated for the treatment of adult patients with Dupuytren's contracture with a palpable cord.
|1.||XIAFLEX® [package insert]. Malvern, PA: Endo Pharmaceuticals Inc.|
|2.|| Starkweather KD, Lattuga S, Hurst LC, et al. Collagenase in the treatment of Dupuytren’s disease: an in vitro study. J Hand Surg Am. |
|3.||Data on file. DOF-XDC-18. Endo Pharmaceuticals Inc; September 14, 2015.|
|4.||Desai SS, Hentz VR. The treatment of Dupuytren disease. J Hand Surg Am. 2011;36(5):936-942.|
|5.||Brandt KE. An evidence-based approach to Dupuytren’s contracture. Plast Reconstr Surg. 2010;126(6):2210-2215.|
|6.||Hay DC, Louie DL, Earp BE, Kaplan FT, Akelman E, Blazar PE. Surgical findings in the treatment of Dupuytren’s disease after initial treatment with clostridial collagenase (Xiaflex). J Hand Surg Eur Vol. 2014;39(5):463-465.|